168 related articles for article (PubMed ID: 22865383)
1. In vitro susceptibility and cellular uptake for a new class of antimicrobial agents: dinuclear ruthenium(II) complexes.
Li F; Feterl M; Mulyana Y; Warner JM; Collins JG; Keene FR
J Antimicrob Chemother; 2012 Nov; 67(11):2686-95. PubMed ID: 22865383
[TBL] [Abstract][Full Text] [Related]
2. The antimicrobial activity of inert oligonuclear polypyridylruthenium(II) complexes against pathogenic bacteria, including MRSA.
Li F; Mulyana Y; Feterl M; Warner JM; Collins JG; Keene FR
Dalton Trans; 2011 May; 40(18):5032-8. PubMed ID: 21442118
[TBL] [Abstract][Full Text] [Related]
3. Chlorido-containing ruthenium(II) and iridium(III) complexes as antimicrobial agents.
Pandrala M; Li F; Feterl M; Mulyana Y; Warner JM; Wallace L; Keene FR; Collins JG
Dalton Trans; 2013 Apr; 42(13):4686-94. PubMed ID: 23360972
[TBL] [Abstract][Full Text] [Related]
4. Protein binding by dinuclear polypyridyl ruthenium(II) complexes and the effect of cucurbit[10]uril encapsulation.
Li F; Feterl M; Warner JM; Day AI; Keene FR; Collins JG
Dalton Trans; 2013 Jun; 42(24):8868-77. PubMed ID: 23657293
[TBL] [Abstract][Full Text] [Related]
5. Tri- and tetra-nuclear polypyridyl ruthenium(II) complexes as antimicrobial agents.
Gorle AK; Feterl M; Warner JM; Wallace L; Keene FR; Collins JG
Dalton Trans; 2014 Nov; 43(44):16713-25. PubMed ID: 25271478
[TBL] [Abstract][Full Text] [Related]
6. Dinuclear polypyridylruthenium(II) complexes: flow cytometry studies of their accumulation in bacteria and the effect on the bacterial membrane.
Li F; Feterl M; Warner JM; Keene FR; Collins JG
J Antimicrob Chemother; 2013 Dec; 68(12):2825-33. PubMed ID: 23873648
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of carbene complexes of rhodium(I) and ruthenium(II).
Cetinkaya B; Cetinkaya E; Küçükbay H; Durmaz R
Arzneimittelforschung; 1996 Aug; 46(8):821-3. PubMed ID: 9125286
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of cytotoxicity and cellular uptake of lipophilic inert dinuclear polypyridylruthenium(II) complexes.
Pisani MJ; Fromm PD; Mulyana Y; Clarke RJ; Körner H; Heimann K; Collins JG; Keene FR
ChemMedChem; 2011 May; 6(5):848-58. PubMed ID: 21472992
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
10. An approach to therapeutic agents through selective targeting of destabilised nucleic acid duplex sequences.
Li F; Weber DK; Morgan JL; Collins JG; Keene FR
Dalton Trans; 2012 Jun; 41(21):6528-35. PubMed ID: 22311066
[TBL] [Abstract][Full Text] [Related]
11. Oligonuclear polypyridylruthenium(II) complexes: selectivity between bacteria and eukaryotic cells.
Gorle AK; Li X; Primrose S; Li F; Feterl M; Kinobe RT; Heimann K; Warner JM; Keene FR; Collins JG
J Antimicrob Chemother; 2016 Jun; 71(6):1547-55. PubMed ID: 26945708
[TBL] [Abstract][Full Text] [Related]
12. Mononuclear Polypyridylruthenium(II) Complexes with High Membrane Permeability in Gram-Negative Bacteria-in particular Pseudomonas aeruginosa.
Gorle AK; Feterl M; Warner JM; Primrose S; Constantinoiu CC; Keene FR; Collins JG
Chemistry; 2015 Jul; 21(29):10472-81. PubMed ID: 26042390
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Properties of Tris(homoleptic) Ruthenium(II) 2-Pyridyl-1,2,3-triazole "Click" Complexes against Pathogenic Bacteria, Including Methicillin-Resistant Staphylococcus aureus (MRSA).
Kumar SV; Scottwell SØ; Waugh E; McAdam CJ; Hanton LR; Brooks HJ; Crowley JD
Inorg Chem; 2016 Oct; 55(19):9767-9777. PubMed ID: 27657170
[TBL] [Abstract][Full Text] [Related]
14. Dinuclear ruthenium(ii) complexes containing one inert metal centre and one coordinatively-labile metal centre: syntheses and biological activities.
Li X; Heimann K; Li F; Warner JM; Richard Keene F; Grant Collins J
Dalton Trans; 2016 Mar; 45(9):4017-29. PubMed ID: 26841356
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and antimicrobial activity of chromium(III) and ruthenium(II) complexes on Staphylococcus aureus and Escherichia coli.
Páez PL; Bazán CM; Bongiovanni ME; Toneatto J; Albesa I; Becerra MC; Argüello GA
Biomed Res Int; 2013; 2013():906912. PubMed ID: 24093107
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial and antifungal activities of complexes of ruthenium (II).
Cetinkaya B; Ozdemir I; Binbaşioğlu B; Durmaz R; Günal S
Arzneimittelforschung; 1999 Jun; 49(6):538-40. PubMed ID: 10417872
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, isomerisation and biological properties of mononuclear ruthenium complexes containing the bis[4(4'-methyl-2,2'-bipyridyl)]-1,7-heptane ligand.
Sun B; Southam HM; Butler JA; Poole RK; Burgun A; Tarzia A; Keene FR; Collins JG
Dalton Trans; 2018 Feb; 47(7):2422-2434. PubMed ID: 29379923
[TBL] [Abstract][Full Text] [Related]
18. Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.
Lemmen SW; Zolldann D; Klik S; Lütticken R; Kümmerer K; Häfner H
Chemotherapy; 2004 Apr; 50(1):27-30. PubMed ID: 15084802
[TBL] [Abstract][Full Text] [Related]
19. Development of ruthenium(II) complexes as topical antibiotics against methicillin resistant Staphylococcus aureus.
Lam PL; Lu GL; Hon KM; Lee KW; Ho CL; Wang X; Tang JC; Lam KH; Wong RS; Kok SH; Bian ZX; Li H; Lee KK; Gambari R; Chui CH; Wong WY
Dalton Trans; 2014 Mar; 43(10):3949-57. PubMed ID: 24448670
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium Complexes with 2-Pyridin-2-yl-1
Jabłońska-Wawrzycka A; Rogala P; Czerwonka G; Gałczyńska K; Drabik M; Dańczuk M
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
